Thomas Mayer to Anticonvulsants
This is a "connection" page, showing publications Thomas Mayer has written about Anticonvulsants.
Connection Strength
0.842
-
Pre- rather than co-application of vigabatrin increases the efficacy of tiagabine in hippocampal slices. Epilepsia. 2002 Dec; 43(12):1455-61.
Score: 0.205
-
Lacosamide in the treatment of patients with epilepsy and intellectual disabilities: A long-term study of 136 patients. Epilepsia. 2017 10; 58(10):1749-1754.
Score: 0.142
-
A noninterventional study evaluating the effectiveness and safety of lacosamide added to monotherapy in patients with epilepsy with partial-onset seizures in daily clinical practice: The VITOBA study. Epilepsia. 2015 Dec; 56(12):1921-30.
Score: 0.125
-
Dose-dependent suppression of human photoparoxysmal response with the competitive AMPA/kainate receptor antagonist BGG492: Clear PK/PD relationship. Epilepsia. 2015 Jun; 56(6):924-32.
Score: 0.121
-
A multicenter survey of clinical experiences with perampanel in real life in Germany and Austria. Epilepsy Res. 2014 Jul; 108(5):986-8.
Score: 0.112
-
Perioral reflex myoclonias: a controlled study in patients with JME and focal epilepsies. Epilepsia. 2006 Jun; 47(6):1059-67.
Score: 0.065
-
Efficacy, tolerability, and retention of fenfluramine for the treatment of seizures in patients with Dravet syndrome: Compassionate use program in Germany. Epilepsia. 2021 10; 62(10):2518-2527.
Score: 0.047
-
Concentrations of stiripentol in children and adults with epilepsy: the influence of dose, age, and comedication. Ther Drug Monit. 2012 Aug; 34(4):390-7.
Score: 0.025